Your browser doesn't support javascript.
loading
Prolactinoma: Medical and Surgical Considerations.
Haider, Sameah A; Levy, Shiri; Rock, Jack P; Craig, John R.
Afiliação
  • Haider SA; Department of Neurological Surgery, Hermelin Brain Tumor Center, Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, MI 48202, USA.
  • Levy S; Division of Endocrinology, Diabetes, and Bone & Mineral Disorder, Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, MI 48202, USA.
  • Rock JP; Department of Neurological Surgery, Hermelin Brain Tumor Center, Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, MI 48202, USA.
  • Craig JR; Department of Otolaryngology-Head and Neck Surgery, Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, MI 48202, USA. Electronic address: Jcraig1@hfhs.org.
Otolaryngol Clin North Am ; 55(2): 305-314, 2022 Apr.
Article em En | MEDLINE | ID: mdl-35256169
ABSTRACT
Prolactinomas are the most common secretory tumor of the pituitary gland. Clinical symptoms may be due to prolactin oversecretion, localized mass effect, or a combination of both. Although the mainstay of prolactinoma management is medical therapy with dopamine agonists, endoscopic endonasal or transcranial surgery, radiation therapy, or a combination of these is an important treatment option in select cases. This article discusses prolactinoma phenotypes, clinical presentations, and clinically pertinent medical and surgical considerations when managing these tumors.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Hipofisárias / Prolactinoma Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Hipofisárias / Prolactinoma Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article